MARKET

PSNL

PSNL

Personalis
NASDAQ
14.93
-0.87
-5.48%
Opening 13:18 07/16 EDT
OPEN
15.49
PREV CLOSE
15.79
HIGH
15.75
LOW
14.82
VOLUME
2.48M
TURNOVER
--
52 WEEK HIGH
16.15
52 WEEK LOW
3.840
MARKET CAP
1.56B
P/E (TTM)
-14.6770
1D
5D
1M
3M
1Y
5Y
1D
Personalis President, CMO Richard Chen sells 100,000 shares for $1.52 million
PUBT · 15h ago
Personalis’ NeXT Personal test granted UKCA marking
TipRanks · 2d ago
Personalis Achieves UK Conformity Assessed Designation For Its NeXT Personal Dx Test
Benzinga · 2d ago
Personalis partners with Link Medical Solutions to commercialize NeXT Personal Dx in Great Britain
PUBT · 2d ago
Personalis wins UKCA mark for NeXT Personal Dx MRD test in Great Britain
PUBT · 2d ago
Tempus AI: Building Ultimate Healthcare Data Dominance
Seeking Alpha · 2d ago
Cathie Wood reshuffles portfolio ahead of Q2, buys SpaceX, Eli Lilly, Meta; pares AMD, Roku
Seeking Alpha · 3d ago
Weekly Report: what happened at PSNL last week (0706-0710)?
Weekly Report · 3d ago
More
About PSNL
Personalis, Inc. is engaged in developing, marketing and selling advanced cancer genomic tests and analytics. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other cancer immunotherapies. Its products include NeXT Personal, ImmunoI DNeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). NeXT Personal is a tumor-informed liquid biopsy test for the detection of minimal residual disease (MRD) and recurrence in cancer. NeXT Dx is a comprehensive tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. The Company performed WGS on human samples for research projects, such as population sequencing initiatives. The Company’s tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and the development of personalized cancer therapies.

Webull offers Personalis Inc stock information, including NASDAQ: PSNL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSNL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PSNL stock methods without spending real money on the virtual paper trading platform.